Exposure to polycyclic aromatic hydrocarbons and serum inflammatory markers of cardiovascular disease

Environmental Research

Volumn 117, Issue , 2012, Pages 132-137

  Clark, John D ^a   Serdar, Berrin ^b   Lee, David J ^a   Arheart, Kristopher ^a   Wilkinson, James D ^a   Fleming, Lora E ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Global Health and Health Disparities   (United States)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cardiovascular disease; Fibrinogen; Homocysteine; Polycyclic aromatic hydrocarbons; White blood cells

Indexed keywords

FIBRINOGEN; FLUORENE; HOMOCYSTEINE; NAPHTHALENE; PHENANTHRENE; POLYCYCLIC AROMATIC HYDROCARBON; PYRENE;

CARCINOGEN; CARDIOVASCULAR DISEASE; DATA SET; GENETIC MARKER; METABOLITE; NUMERICAL MODEL; PAH; POLLUTION EXPOSURE; SERUM; SMOKING; TOBACCO;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; ENVIRONMENTAL EXPOSURE; ETHNICITY; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RACE; SEX DIFFERENCE; SMOKING HABIT;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; FIBRINOGEN; FLUORENES; HOMOCYSTEINE; HUMANS; LEUKOCYTE COUNT; LINEAR MODELS; MALE; MIDDLE AGED; NAPHTHALENES; PHENANTHRENES; POLYCYCLIC HYDROCARBONS, AROMATIC; PYRENES; UNITED STATES;

NICOTIANA TABACUM;

EID: 84864929811     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2012.04.012     Document Type: Article

References (34)

1. Albert R.E., Vanderlaan M., Burns F.J., Nishizumi M., Albert R.E., Vanderlaan M., Burns F.J., Nishizumi M. Effect of carcinogens on chicken atherosclerosis. Cancer Res. 1977, 37:2232-2235.
2. A.T.S.D.R. Toxicological profile for polycyclic aromatic hydrocarbons (PAHs). Agency for Toxic Substances and Disease Registry, Atlanta 1995, 485.
3. Bartle K. Analysis and occurrence of polycyclic aromatic hydrocarbons in food. Food Contaminants: Sources and Surveillance 1991, The Royal Society of Chemistry, Cambridge. C. Creaser, R. Purchase (Eds.).
4. Bassuk S.S., Rifai N., Ridker P.M., Bassuk S.S., Rifai N., Ridker P.M. High-sensitivity C-reactive protein: clinical importance. Curr. Probl. Cardiol. 2004, 29:439-493.
5. Bazzano L.A., He J., Muntner P., Vupputuri S., Whelton P.K. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann. Intern. Med. 2003, 138:891-897. (summary for patients in Ann Intern Med. 2003 Jun 3;138(11):I45; PMID: 12779312).
6. Burstyn I., Kromhout H., Partanen T., Svane O., Langard S., Ahrens W., Kauppinen T., Stucker I., Shaham J., Heederik D., Ferro G., Heikkila P., Hooiveld M., Johansen C., Randem B.G., Boffetta P., Burstyn I., Kromhout H., Partanen T., Svane O., Langard S., Ahrens W., Kauppinen T., Stucker I., Shaham J., Heederik D., Ferro G., Heikkila P., Hooiveld M., Johansen C., Randem B.G., Boffetta P. Polycyclic aromatic hydrocarbons and fatal ischemic heart disease. Epidemiology 2005, 16:744-750.
7. C.D.C. Third National Report on Human Exposure to Environmental Chemicals. Centers for Disease Control and Prevention (CDC) 2005, Department of Health and Human Services (DHHS).
8. Cohen Hubal E.A., Sheldon L.S., Burke J.M., McCurdy T.R., Berry M.R., Rigas M.L., Zartarian V.G., Freeman N.C. Children's exposure assessment: a review of factors influencing children's exposure, and the data available to characterize and assess that exposure. Environ. Health Perspect. 2000, 108:475-486.
9. Curfs D.M.J., Knaapen A.M., Pachen D.M.F.A., Gijbels M.J.J., Lutgens E., Smook M.L.F., Kockx M.M., Daemen M.J.A.P., van Schooten F.J. Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. FASEB J. 2005, 19:1290-1292.
10. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998, 279:1477-1482.
11. Dominici F., Peng R.D., Bell M.L., Pham L., McDermott A., Zeger S.L., Samet J.M., Dominici F., Peng R.D., Bell M.L., Pham L., McDermott A., Zeger S.L., Samet J.M. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA 2006, 295:1127-1134.
12. Evanoff B.A., Gustavsson P., Hogstedt C., Evanoff B.A., Gustavsson P., Hogstedt C. Mortality and incidence of cancer in a cohort of Swedish chimney sweeps: an extended follow up study. Br. J. Ind. Med. 1993, 50:450-459.
13. Everett C.J., King D.E., Player M.S., Matheson E.M., Post R.E., Mainous A.G. Association of urinary polycyclic aromatic hydrocarbons and serum C-reactive protein. Environ. Res. 2010, 110:79-82.
14. Hansen E.S., Hansen E.S. Mortality from cancer and ischemic heart disease in Danish chimney sweeps: a five-year follow-up. Am. J. Epidemiol. 1983, 117:160-164.
15. Kannel W.B., Kannel W.B. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005, 40:1215-1220.
16. Mensah G.A., Brown D.W., Croft J.B., Greenlund K.J., Mensah G.A., Brown D.W., Croft J.B., Greenlund K.J. Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the second National Health and Nutrition Examination Survey (NHANES II). Am. J. Prev. Med. 2005, 29:68-74.
17. NHANES, 2001. Laboratory Procedures Manual, vol. 2008.
18. N.H.A.N.E.S., 2001. Key Concepts About Survey History.
19. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith S.C., Taubert K., Tracy R.P., Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
20. Peel J.L., Metzger K.B., Klein M., Flanders W.D., Mulholland J.A., Tolbert P.E., Peel J.L., Metzger K.B., Klein M., Flanders W.D., Mulholland J.A., Tolbert P.E. Ambient air pollution and cardiovascular emergency department visits in potentially sensitive groups. Am. J. Epidemiol. 2007, 165:625-633.
21. Penn A., Snyder C. Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons. Carcinogenesis 1988, 9:2185-2189.
22. Ridker P.M., Bassuk S.S., Toth P.P., Ridker P.M., Bassuk S.S., Toth P.P. C-reactive protein and risk of cardiovascular disease: evidence and clinical application. Curr. Atheroscler. Rep. 2003, 5:341-349.
23. Ronneberg A., Ronneberg A. Mortality and cancer morbidity in workers from an aluminium smelter with prebaked carbon anodes-part III: mortality from circulatory and respiratory diseases. Occup. Environ. Med. 1995, 52:255-261.
24. Ruckerl R., Greven S., Ljungman P., Aalto P., Antoniades C., Bellander T., Berglind N., Chrysohoou C., Forastiere F., Jacquemin B., von Klot S., Koenig W., Kuchenhoff H., Lanki T., Pekkanen J., Perucci C.A., Schneider A., Sunyer J., Peters A., Group A.S., Ruckerl R., Greven S., Ljungman P., Aalto P., Antoniades C., Bellander T., Berglind N., Chrysohoou C., Forastiere F., Jacquemin B., von Klot S., Koenig W., Kuchenhoff H., Lanki T., Pekkanen J., Perucci C.A., Schneider A., Sunyer J., Peters A. Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ. Health Perspect. 2007, 115:1072-1080.
25. Ruckerl R., Ibald-Mulli A., Koenig W., Schneider A., Woelke G., Cyrys J., Heinrich J., Marder V., Frampton M., Wichmann H.E., Peters A., Ruckerl R., Ibald-Mulli A., Koenig W., Schneider A., Woelke G., Cyrys J., Heinrich J., Marder V., Frampton M., Wichmann H.E., Peters A. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am. J. Respir. Crit. Care Med. 2006, 173:432-441.
26. Schwartz J. Air pollution and blood markers of cardiovascular risk. Environ. Health Perspect. 2001, 109(3):405-409.
27. Suwan-ampai P., Navas-Acien A., Strickland P.T., Agnew J. Involuntary tobacco smoke exposure and urinary levels of polycyclic aromatic hydrocarbons in the United States, 1999-2002. Cancer Epidemiol. Biomarkers Prev. 2009, 18(3):884-893.
28. Taylor A.E., Johnson D.C., Kazemi H., Taylor A.E., Johnson D.C., Kazemi H. Environmental tobacco smoke and cardiovascular disease. a position paper from the Council on Cardiopulmonary and Critical Care. Am. Heart Assoc. Circulation 1992, 86:699-702.
29. Tofler G.H., D'Agostino R.B., Jacques P.F., Bostom A.G., Wilson P.W., Lipinska I., Mittleman M.A., Selhub J., Tofler G.H., D'Agostino R.B., Jacques P.F., Bostom A.G., Wilson P.W.F., Lipinska I., Mittleman M.A., Selhub J. Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk. Thromb. Haemostasis 2002, 88:799-804.
30. Tuchsen F., Andersen O., Costa G., Filakti H., Marmot M.G., Tuchsen F., Andersen O., Costa G., Filakti H., Marmot M.G. Occupation and ischemic heart disease in the European Community: a comparative study of occupations at potential high risk. Am. J. Ind. Med. 1996, 30:407-414.
31. US Department of Health and Human Services, 2005. P. H. S., National Toxicology Program. Report on Carcinogens, Eleventh Edition.
32. Walker B., Mouton C.P., Walker B., Mouton C.P. Environmental influences on cardiovascular health. J. Natl. Med. Assoc. 2008, 100:98-102.
33. Wilkinson J.D., Lee D.J., Arheart K.L. Secondhand smoke exposure and C-reactive protein levels in youth. Nicotine Tob. Res. 2007, 9:305-307.
34. Wilson P.W. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. Circulation 2004, 110. e568-71.